Streetbeat News

Analyst Ratings

PSX

High-rolling investors have shown a bullish sentiment on Phillips 66 (NYSE:PSX), with Benzinga's options scanner revealing 21 significant trades. The sentiment is predominantly bullish with a split of 57% bullish and 42% bearish. Notable trades include a mix of calls and puts with a focus on strike prices ranging from $40.0 to $145.0. Phillips 66, an independent refiner, is currently trading at $145.34, with a volume of 1,852,285 and may be considered overbought based on RSI readings. Analysts from Wells Fargo, Raymond James, and Barclays have issued ratings with a consensus target price of $152.33.

Portfolio Pulse from Benzinga Insights

February 15, 2024 | 8:31 pm

MRK

Investors have shown a bearish stance on Merck & Co (NYSE:MRK) through options trading, with a notable volume of trades indicating a split sentiment but leaning towards bearish. The options market activity suggests targeting a price range of $105.0 to $130.0 for MRK over the last 3 months. Current trading volume and analyst ratings suggest a mixed outlook, with a recent price increase and a potential overbought condition. Analysts have set target prices ranging from $135 to $148, indicating a positive outlook despite the bearish options market sentiment.

Portfolio Pulse from Benzinga Insights

February 15, 2024 | 8:31 pm

MCD

Financial analysis reveals a bearish sentiment among traders towards McDonald's (NYSE:MCD), with 64% of options trades showing bearish tendencies. Notable options activity includes both calls and puts with a focus on strike prices between $280.0 and $310.0. Despite this, McDonald's remains a strong player in the restaurant industry, with system sales of $130 billion and a current stock price of $291.07, up by 1.01%. Analysts have given McDonald's an average target price of $332.0, with ratings ranging from Buy to Outperform.

Portfolio Pulse from Benzinga Insights

February 15, 2024 | 8:01 pm

ENPH

Enphase Energy (NASDAQ:ENPH) has seen significant options market activity, with a bearish sentiment among big-money investors. Benzinga's options scanner revealed 49 unusual trades, with a split sentiment of 36% bullish and 63% bearish. The trades aim for a price range of $90 to $190 in the next three months. Current trading volume is 3,439,093, with a 2.8% price increase to $135.3. Analyst ratings in the last month have an average target price of $120.8, with varying recommendations.

Portfolio Pulse from Benzinga Insights

February 15, 2024 | 8:01 pm

VECO

Veeco Instruments (NASDAQ:VECO) has been evaluated by 4 analysts over the last three months, showing a shift towards a more bullish outlook with an increase in the average 12-month price target to $34.75, up 14.88% from $30.25. The company's financial performance indicates strong revenue growth and net margin, but challenges in ROE and ROA. Veeco's market capitalization is below industry average, suggesting it's smaller compared to peers, yet it has a prudent debt management strategy.

Portfolio Pulse from Benzinga Insights

February 15, 2024 | 8:00 pm

COIN

SARK

TARK

Coinbase Global, Inc (NASDAQ:COIN) is anticipated to release its Q4 financial results, with analysts expecting earnings of 2 cents per share on revenues of $823.85 million. JPMorgan upgraded Coinbase to Neutral with an $80 price target. Investors are keen on Coinbase's Bitcoin and Ethereum trading revenue. For diversified investment, TARK ETF, which includes Coinbase as a top holding, and SARK ETF for bearish positions are options. Technical analysis suggests a mildly bullish outlook for Coinbase but indicates a potential need for a pullback.

Portfolio Pulse from Melanie Schaffer

February 15, 2024 | 7:54 pm

AMZN

NVDA

Josh Brown of Ritholtz Wealth Management suggests the market, particularly the Nasdaq 100, may have reached its peak for the year, citing frenzied buying in stocks like Nvidia (NVDA) as evidence. He notes the Nasdaq 100's over 50% gain in 2023 and its strong start in 2024, driven by AI optimism and operational efficiency. Brown highlights the excessive trading of Nvidia stock, calling it an 'algorithm casino' and a 'freak show', indicative of a market top. He also mentions significant stock movements in other mega-cap tech companies and notable actions by figures like Jeff Bezos and Sam Altman as contributing factors to his view.

Portfolio Pulse from Adam Eckert

February 15, 2024 | 7:43 pm

WMT

Recent analysis of Walmart's (NYSE:WMT) options activity shows a bullish sentiment among investors, with 66% of trades being bullish. Significant trades have targeted a price range of $125.0 to $185.0 for Walmart over the last 3 months. The company's stock price is currently up by 0.42%, with a trading volume of 3,169,471 and an RSI indicating it may be approaching overbought. Analysts have set an average target price of $185.0, with Telsey Advisory Group and Oppenheimer maintaining Outperform ratings.

Portfolio Pulse from Benzinga Insights

February 15, 2024 | 7:30 pm

DLR

Digital Realty Trust (NYSE:DLR) has seen significant options activity indicating a bearish sentiment among big-money investors, with a split of 22% bullish and 77% bearish trades. Notable options trades include both puts and calls with strike prices ranging from $65.0 to $220.0. The company operates over 300 data centers worldwide and is transitioning towards providing higher-level services. Despite the bearish options sentiment, DLR's stock price is up 4.65% at $148.84, with analysts giving mixed ratings and target prices ranging from $110 to $157.

Portfolio Pulse from Benzinga Insights

February 15, 2024 | 7:30 pm

INGN

PHG

Inogen Inc (NASDAQ:INGN) has been upgraded by William Blair from Market Perform to Outperform following Koninklijke Philips NV's (NYSE:PHG) announcement to halt sales of new CPAP, BiPAP, and other respiratory devices in the U.S. until compliance with a consent decree. Philips Respironics will continue operations internationally under specific conditions. The exit of Respironics, a significant market player, presents an opportunity for Inogen to capture a larger market share, potentially up to 50% compared to Respironics' 15%-25%. Despite recent challenges and management changes at Inogen, the analyst views the current valuation and market opportunity as favorable for the company.

Portfolio Pulse from Vandana Singh

February 15, 2024 | 7:30 pm